CareDx, QIAGEN Collaborate
News Jun 02, 2016
CareDx, Inc. has announced it has signed a memorandum of understanding to collaborate with QIAGEN. Under the terms of this commercial collaboration, CareDx will make available to Human Leukocyte Antigen (HLA) laboratories worldwide the proprietary QIAGEN QIAxcel Advanced Instrumentation together with its proprietary Olerup SSP® kits and SCORE™ software. This combined offering will provide transplant labs an additional option for processing and data entry for HLA typing.
"We are excited to be working with QIAGEN, a leader in diagnostic technology. This collaboration fits well with our strategy to partner with leading innovative solution providers and enhance the transplant lab testing workflow," said Anders Karlsson, Chief International Business Officer at CareDx.
"CareDx is a recognized leader in transplant diagnostics. Our collaboration will allow us to bring our QIAxcel solutions to HLA labs around the globe using the CareDx commercial channel," said Thierry Bernard, Senior Vice President and Head of QIAGEN's Molecular Diagnostics Business Area. Financial terms of the collaboration were not disclosed.
Gene Editing Technology May Improve Accuracy of Predicting Heart Disease RiskNews
Scientists may now be able to predict whether carrying a specific genetic variant increases a person’s risk for disease using gene editing and stem cell technologies.READ MORE
Improved Method for Isolating Extracellular RNANews
In a breakthrough that could lead to powerful new ways to diagnose and track a wide range of medical conditions, scientists at The Rockefeller University have devised an improved method for isolating and identifying tiny fragments of RNA in human blood products.READ MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018